Q2 2016 Holdings
Filed 2016-08-15 | 22 holdings | $57.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| ANI Pharmaceuticals Inc(ANIP) | COM | 00182C103 | $45.6M | 817,456 | 79.4% |
| Adma Biologics Inc(ADMA) | COM | 000899104 | $7.6M | 1,273,933 | 13.2% |
| Axogen Inc(AXGN) | COM | 05463X106 | $3.6M | 526,351 | 6.3% |
| Mallinckrodt PUB LTD Co | SHS | G5785G107 | $94.8K | 1,560,157 | 0.2% |
| Medivation Inc | COM | 58501N101 | $76.6K | 1,270,000 | 0.1% |
| Ariad Pharmaceuticals Inc | COM | 04033A100 | $65.4K | 8,845,742 | 0.1% |
| Ironwood Pharmaceuticals Inc(IRWD) | COM CL A | 46333X108 | $64.4K | 4,929,139 | 0.1% |
| Orthofix Intl N V | COM | N6748L102 | $51.9K | 1,224,496 | 0.1% |
| Retrophin Inc | COM | 761299106 | $48.1K | 2,699,947 | 0.1% |
| Depomed Inc | COM | 249908104 | $44.6K | 2,275,300 | 0.1% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $44.3K | 418,700 | 0.1% |
| Penumbra Inc(PEN) | COM | 70975L107 | $40.7K | 684,079 | 0.1% |
| Clovis Oncology Inc(CLVSEUR) | COM | 189464100 | $40.3K | 2,936,487 | 0.1% |
| Eagle Pharmaceuticals Inc(EGRX) | COM | 269796108 | $18.7K | 482,047 | 0.0% |
| Nxstage Medical Inc | COM | 67072V103 | $18.1K | 835,134 | 0.0% |
| Cepheid | COM | 15670R107 | $14.0K | 453,662 | 0.0% |
| Nuvasive Inc(NUVAGBP) | COM | 670704105 | $9.9K | 165,203 | 0.0% |
| Pacific Biosciences Calif in(PACB) | COM | 69404D108 | $7.8K | 1,114,448 | 0.0% |
| Vericel Corp(VCEL) | COM | 92346J108 | $5.0K | 2,232,940 | 0.0% |
| Seaspine Hldgs Corp(SPNEUSD) | COM | 81255T108 | $2.7K | 255,334 | 0.0% |
| Biolase Inc | COM | 090911108 | $1.5K | 1,257,292 | 0.0% |
| Veracyte Inc(VCYT) | COM | 92337F107 | $834 | 165,825 | 0.0% |